Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy

Open Access Macedonian Journal of Medical Sciences - Macedonia
doi 10.3889/oamjms.2019.759
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

ID Design 2012/DOOEL Skopje

Related search

A Cross Talk Between Class a Scavenger Receptor and Receptor for Advanced Glycation End-Products Contributes to Diabetic Retinopathy

American Journal of Physiology - Endocrinology and Metabolism
EndocrinologyPhysiologyMetabolismDiabetes
2014English

Reduced Soluble Receptor for Advanced Glycation End-Products in COPD

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Receptor-Mediated Endothelial Cell Dysfunction in Diabetic Vasculopathy. Soluble Receptor for Advanced Glycation End Products Blocks Hyperpermeability in Diabetic Rats.

Journal of Clinical Investigation
Medicine
1996English

Pterostilbene Alleviates Diabetic Nephropathy in Experimental Diabetic Rats; Inhibition of Aldose Reductase and Advanced Glycation End Products Formation

Endocrinology&Metabolism International Journal
2017English

Advanced Glycation End Products (AGEs) Promote Melanogenesis Through Receptor for AGEs

Scientific Reports
Multidisciplinary
2016English

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury

Circulation
Cardiovascular MedicinePhysiologyCardiology
2006English

Zinc Against Advanced Glycation End Products

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2018English

CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Identification of C1q as a Binding Protein for Advanced Glycation End Products

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy